BIOMEDICAL RESEARCH FOUNDATION, ACADEMY OF ATHENS (BRFAA) - - - PowerPoint PPT Presentation

biomedical research foundation academy of athens brfaa
SMART_READER_LITE
LIVE PREVIEW

BIOMEDICAL RESEARCH FOUNDATION, ACADEMY OF ATHENS (BRFAA) - - - PowerPoint PPT Presentation

BIOMEDICAL RESEARCH FOUNDATION, ACADEMY OF ATHENS (BRFAA) - www.bioacademy.gr RESEARCH DIRECTIONS CARDIOVASCULAR NEUROBIOLOGY BIOLOGY OF STRESS ! Metabolic Diseases ! Development ! Development ! Diabetes Obesity ! Physiology - Pathology !


slide-1
SLIDE 1

BIOMEDICAL RESEARCH FOUNDATION, ACADEMY OF ATHENS (BRFAA) - www.bioacademy.gr

slide-2
SLIDE 2

RESEARCH DIRECTIONS

CARDIOVASCULAR

NEUROBIOLOGY

! Development ! Physiology - Pathology ! Cellular Death

REGULATION OF GENE EXPRESSION INFLAMMATION-TISSUE REMODELING

GENETICS OF AGEING CANCER BIOLOGY

! Basic Molecular Mechanisms ! Gene Expression Networks ! Genetic re-programming ! Severe Asthma ! Chronic Obstructive Pulmonary Disease ! Interstitial Lung Diseases ! Renal Failure ! Rheumatoid Arthritis ! Ulcerative Colitis, Crohn’s Disease ! Mechanisms of carcinogenesis ! Novel Markers ! Cutting edge methodologies for: ! Treatment and diagnosis ! Gene Therapy ! New drugs ! Development ! Neurodegenerative Diseases ! Memory and Learning ! Metabolic Diseases ! Diabetes Obesity ! Systemic Responses ! In C. elegans ! Telomeres ! Systemic analysis

BIOLOGY OF STRESS

slide-3
SLIDE 3

Dimitris Beis, Ph.D George P Chrousos MD, MACP, MACE Katia Karalis MD, Ph.D Elias S. Manolakos, Ph.D Stamatis N. Pagakis, Ph.D Irini Skaliora, Ph.D Leonidas Stefanis, MD, Ph.D Constantin Tamvakopoulos, Ph.D Demetrios K. Vassilatis, Ph.D Konstantinos Vekrellis, Ph.D Antonia Vlahou, Ph.D

  • Prof. Stefan R. Bornstein, Ph.D.
  • Prof. Deniz Kirik, M.D. Ph.D
  • Prof. Vasilis Ntziachristos Ph.D
  • Prof. Jonathan Seckl

Dimitris Kalamatianos Sevi Karaliota Charalambos Sigalas Alexia Polissidis Panagiotis Tsakanikas

slide-4
SLIDE 4

MAIN MISSION OF BRFAA : THE CATALYSIS OF TRANSLATIONAL RESEARCH

BIOMEDICAL APPLICATIONS

slide-5
SLIDE 5

CENTER FOR CLINICAL RESEARCH

Positron emission Tomography

Cardiovascular Disorders Metabolic Diseases Hematological Diseases Positron Emission Tomography Neurodegenerative Diseases Respiratory Diseases

Onassis Cardiac Surgery Center, Attikon Hospital, Ippokrateio Hospital, Agia Sofia Children’s Hospital, University of Thessaly Hospital, !"#$! Hospital in Thessalonica, University of Thrace Hospital Agia Sofia Children’s Hospital (24000 patients / year), Evaggelismos Hospital Attikon Hospital, University of Thessaly Hospital, University of Patras Evaggelismos Hospital, Sotiria, Sismanoglio, Attikon Hospital, Ippokrateio Hospital, University of Thessaly Hospital, !"#$! Hospital in Thessalonica, University of Thrace Hospital, University of Patras, University of Crete, University of Ioannina etc. 6 semi-intensive care Patient beds Echocardiography Facility

slide-6
SLIDE 6

CENTER FOR EXPERIMENTAL SURGERY

A team of investigators performing a heart operation in a pig, in one

  • f the three Surgical Suites of the Centre.

Fully equipped surgery units capable of supporting broad range of surgical procedures (>2000) in animal models (mice, rats, rabbits, pigs). Intensive Care Unit for post operative monitoring and support of the experimental animals Medical Imaging Unit, analyses with the aid of State-of the – Art methodology such as X-Ray, Ultrasound, Computer and Magnetic Resonance Tomography.

Highly trained animal caretaker handling experimental animals in IVF cages

1600 m2, supporting ~8.000 mice and rats, 70 rabbits and 20 pigs. SPF conditions in individually ventilated cages. Animals housed under the guidelines of the European Convention 123/Council of Europe and Directive 86/609/EEC), «AAALAC Int.», and «FELASA». Soon the capacity of the Animal House will increase to 16.000. Within the next two years a new animal house will raise the capacity to 80.000 mice.

ANIMAL HOUSE

slide-7
SLIDE 7

PROTEOMICS GENOMICS CYTOGENETICS

SUPPORT FACILITIES AT BRFAA

Transgenics Laser Micro-dissection FACS-SORTING Lung Function Measurements BIOIMAGING

slide-8
SLIDE 8

Image Prep MALDI TOF-TOF Autoflex (Bruker)

Proteomics

Orbitrap (Thermo) Tissue Imaging Protein Identification, Quantitation, Post Translational Modification Large-scale analysis of proteins

slide-9
SLIDE 9

BioImaging Facility

Two Upright Imaging Microscopes With CCD Cameras Inverted Confocal and Live Cell imaging System LEICA SP5

Image Analysis Workstations

Calcium photometry/imaging Three Inverted Imaging Microscopes With CCD Cameras NETWORK Upright Confocal And Deconvolution Workstation LEICA SP5 II Neurolucida and Stereo Investigator Workstation with Colour CCD Camera Noldus Animal Behaviour Analysis System Fluorescence Dissection Microscope with Camera

NAS Server

slide-10
SLIDE 10

Noldus Ethovision XT8

  • Video tracking software for

behaviour experiments

  • Morris water maze, open field,

elevated plus maze, etc

slide-11
SLIDE 11

Stereology Workstation for unbiased Counting and Volumetric Data Measurement

STEREO INVESTIGATOR Unbiased Stereological measurements: Quantify cell counts, lengths, areas and volumes. NEUROLUCIDA Neuro-anatomical analysis system for Neuron Tracing, 3D mapping, Image Analysis and Morphometry.

slide-12
SLIDE 12

! 1 Target: Familial Mutations Identified ! An Additional Target is Explored ! Neuroprotective Effects in Cell Lines ! Characterized Molecular Mechanism ! Created PD Animal Models in Mice ! In Silico Chemistry ! Medicinal Chemistry ! Brain Penetration ! Lead Compound identified ! Pharmacokinetics ! Compound Metabolism ! Disease Modification

slide-13
SLIDE 13

Neurodegenerative diseases (1)

  • A. Establishment of collaboration between BRFAA and Lund University
  • B. Transfer of knowledge for :
  • a. Production and delivery of high purity viral vectors in rodent brain (mouse, rat)
  • b. Use of such vectors for the generation of PD animal models
  • c. Screening of potential therapeutic targets
  • d. Identification of Lamp2a as a target for Parkinson’s disease

(Xilouri et al, Brain 2013) Use of: Neurolucida and StereoInvestigator Software to accurately visualize and quantify neuronal cells in tissues

slide-14
SLIDE 14
  • Development of novel, ultra-sensitive ELISA assays to quantify a-synuclein in

biological fluids (CSF, blood plasma and serum, ISF) and media from cell culture (iPS cells – Collaborations with University of Oxford and Hellenic Pasteur Institute)

  • 1. Biomarker search
  • 2. Validation of therapeutic compounds using in vivo microdialysis in PD

mouse models

  • Assessment of the immunobinding efficacy of a new antibody to be used for

PD immunotherapy - Collaboration with BIOGEN Idec.

  • Assessment of the ability of a new compound to reduce the levels of

extracellular a-synuclein in the brain – Collaboration with reMYND (Belgium)

  • 3. Looking at the extracellular space using in vivo microdialysis and

reverse microdialysis

  • Investigation of cellular secretory pathways in mouse brain
  • Characterization of new PD mouse models (synuclein BAC mouse,

Collaboration with University of Oxford)

Neurodegenerative diseases (2)

slide-15
SLIDE 15

Zebrafish offer an alternative strategy for drug discovery (phenotype-driven instead of target-driven)

slide-16
SLIDE 16

external fertilization plethora of progeny Add the chemical of your choice

>20 embryos per well for 5 days (small volume, statistically significant numbers)

Arrhythmic fish / Long QT test Heart function at the cellular level in vivo Aortic stenosis

slide-17
SLIDE 17

An in vivo phenotypic screen of 90 anthranilamide analogues gave 7 new antiangiogenic molecules

!

"#$%&#' (')!!(* ('+*!,*

  • "%*).+/

01#2 "%*).*3 "%*).+* "%*).+/ 456# (789.::/ (789.:3) ;<=>?@ ) +)) /ABCD D-B- //B:: :-BC- +-B:* AB-D A/BC)D ) *) 3)

  • )

D) +))

!"#$%#&#'#($"()"*$+#(+,$,-#-"./01-2"" EEE! !!EEE! EEE! !!EEE! EEE! !EEE! EE! !!!EEE!

slide-18
SLIDE 18

Development Research

Biology, Chemistry, Pharmacology

In silico Hit/Lead selection

Development Launch Hit Identification Lead Identification Lead Optimization Clinical Trials Target Identi- fication Target Validation

Drug metabolism Toxicology Bio-equivalence All the Divisions

  • f Basic Research I & II

Immunology & Transplantations Cancer Biology Systems Biology Biobank Basic Knowledge High throughput analysis Novel Targets Biochemical Assays Cellular Assays In-vivo Models Pharmacology/Pharmacotechnology Biotechnology (Proteomics-Genomics) Clinical Trials Studies in Large Animals Biochemical Assays Cellular Assays In-vivo Models All the Divisions

  • f Basic Research I & II

Immunology & Transplantations Tumor Biology Systems Biology All the Divisions of Experimental Medicine

Clinical Research Fast followers

Increase of semi- intensive care beds to 20

CancerBiology

slide-19
SLIDE 19

DIVISION OF PHARMACOLOGY - PHARMACOTECHNOLOGY

The lab is equipped with Hybrid system of Liquid Chromatography – Mass Spectroscopy of triple quadrupole – Ion trap (LC-MS/MS), and all the

  • ther equipment that are required to perform

bioanalysis and validation of drugs. The laboratory operates according to the Good Laboratory Practice (GLP) standards and has been awarded an ISO/IEC 17025:2005 certificate.

  • Unknown compound analysis (Q1 MS, MS/MS, MS/MS/MS)
  • Qualitative/ Quantitative analysis of drugs in biological fluids/tissues
  • Pharmacokinetics (PK) of drugs in pre-clinical/clinical stages
  • Drug metabolism
  • Bioavailability and bioequivalence studies
  • Quantitative determination of biomarkers (e.g. peptides, proteins) in various

matrices (e.g. plasma)

slide-20
SLIDE 20

literature

New biomarkers New therapeutics Stratification of patients

Database

20 40 60 80 100 100 80 60 40 20 100-Specificity Sensitivity

statistics clinical data

Human

samples

Models

  • omics

In silico model 1 modelling

validation

model of disease

Already available and prospectivel y collected Specificall y generated data

Creatinine ( micromol/l ) Cholesterol (mmol/l) Urinary albumin/creatinine Gender Age Creatinine ( micromol/l ) Cholesterol (mmol/l) Urinary albumin/creatinine Gender Age

Modified from Nephrol Dial Transplant. 2010;25(4):1015-8

Biomarker discovery: integrative approach

slide-21
SLIDE 21

Discovery of biomarkers : Experimental workflow

Urine Models

20 40 60 80 100 100 80 60 40 20 100-Specificity Sensitivity

Statistical association biological process molecular function cellular component Proteomics Verification Clinical samples Functional studies

slide-22
SLIDE 22

Beyond the State-of-the-Art

  • The Pharmacology – Pharmacotechnology

Laboratory is moving beyond the state-of-the-art by acquiring the newer NanoSpray technology which will upgrade all analyses.

  • The low-flow interface (nL/min) will allow

increased sensitivity while the high pressure nanoLC system will afford higher chromatographic separation/resolution

UltiMate 3000 RSLCnano Rapid Separation Nano LC System Proxeon Nano Source

slide-23
SLIDE 23

Vs. microLC-MRM nanoLC-MRM

PGE2-d4 100 pg on column PGE2-d4 1 pg on column

" Installation of the Nano-Spray Technology in Pharmacology lab allowed an increase in sensitivity of 100-fold. Technological Advancements

slide-24
SLIDE 24

The Animal Behavior Facility

slide-25
SLIDE 25

Behavioral phenotyping applications

! Genetic manipulations ! Ageing ! Potential pharmaceuticals ! Ultimate goal: translational medicine ! multifaceted approach to behavioral testing in animal models of human disease

slide-26
SLIDE 26

Available behavioral tests (1)

!"#$%&'($)*&+,"-* ./0&12"+3* !"#"$"%"&'(#)*+%,' '

  • ./0'1/23'4+%5'

*+3/"'%&(#6+07' 8"94(&/' ' :"%"&'#""&3+0()"0' ;'<(2(0#/' /7='>(&6+08"0?8' 3+8/(8/'' @"%(&"3' >"2/'%/8%' A,2+03/&'%/8%'' B/($'%&(*/&8(2' C""%.&+0)07' D&+.'8%&/07%5'' ' >(+0'(88/88$/0%' E"%'.2(%/' ' ' F"#+(2'</5(*+"&' F"#+(<+2+%,'#5($</&' ' '

slide-27
SLIDE 27

Available behavioral tests (2)

!"#$%&'($)*&+,"-* ./0&12"+3* G0H+/%,' I2/*(%/3'.2J8'$(K/' !+75%'3(&6'<"H'

  • ./0'1/23'L#/0%/&'*8='

./&+$/%/&M' N/.&/88+"0' C"&#/3'84+$'%/8%' O(+2'8J.8/08+"0' ' ' !/(&0+07';' $/$"&,' /7='G2K5/+$/&?8' 3+8/(8/'' G#)*/P.(88+*/'(*"+3(0#/'

  • <Q/#%'&/#"70+)"0P2"#()"0'

:"&&+8'4(%/&'$(K/' RS(&$'&(3+(2'$(K/' GT/0)"0';' 8/08"&+$"%"&' 7()07' /7='8#5+K".5&/0+(' G#"J8)#'8%(&%2/'#5($</&' '

slide-28
SLIDE 28

ELECTROPHYSIOLOGY

  • Study of the electrical properties of molecules, cells,

tissues or organs.

  • Measures voltage changes or electric current to make

inferences about function

  • Can study physiological and pathological function of

biological systems over a wide spectrum, ranging from single ion channels (e.g. nicotinic Acetylcholine receptor) to whole organs (e.g. brain, heart etc.)

  • Drug assessment
slide-29
SLIDE 29

ELECTROPHYSIOLOGY equipment

tissue chamber microelectrode signal amplification and data acquisition

slide-30
SLIDE 30

ELECTROPHYSIOLOGY techniques (in vitro and in vivo)

  • Cell attached recordings (single or population

ion channel function in a cell)

  • Whole cell intracellular recordings (cell

function)

  • Single or multi unit recording (single cell or

network activity in a tissue or organ)

  • Field potential recordings (network function of

tissue or organ)

Whole cell recording Action potential CHANNEL CLOSED - CHANNEL OPEN -

Micro-electrode Neuron Micro-electrode Brain slice Micro-electrode Local Field Potential Multi Unit Activity

slide-31
SLIDE 31

ELECTROPHYSIOLOGY Our focus

  • Study brain network function by means of

spontaneous network activity

  • Propose an endophenotype of physiological and

pathological brain function (e.g. Impaired in Alzheimer’s disease, etc.)

  • We have a mouse model of accelerated cognitive

aging

  • Lacks the %2 subunit of the nicotinic acetylcholine

receptor

  • Neurodegeneration
  • Behavioural impairements
  • We find altered network dynamics in brain slice

preparations of %2 knock-out mice

Epilepsy: Interictal and ictal EEG seizures.

Humans In vitro

Silva et al. (Science, 1991)

Interictal Ictal

Pharmacology of interictal- and ictal-like epileptiform activity in vitro.

slide-32
SLIDE 32

Mouse metabolism facility: physiology and pathophysiology

slide-33
SLIDE 33

Altered metabolism is at the heart of serious health problems such as

  • obesity
  • diabetes
  • CVDs
  • cancer
  • hypertension
  • endothelial dysfunction
  • oxidative stress
  • inflammation
  • fatty liver disease (NASH)

WHY ?

slide-34
SLIDE 34

Comprehensive Lab Animal Monitoring System (CLAMS) Open circuit indirect calorimetry system that provides high quality metabolic phenotyping analysis

  • Metabolic Measurements:

# Energy expenditure # Respiratory Exchange Ratio (RER) # Feeding measurements

  • Activity measurements:

# Rearing axis (ZTOT) # Ambulatory (AMB)

slide-35
SLIDE 35

CLAMS Analysis

slide-36
SLIDE 36

Functional assessment

Cardiovascular function

Blood pressure measurement system

Vivid 7, GE Healthcare system

Echopac PC SW 3.1.3 software (GE Healthcare) (In collaboration with Cardiovascular Research Unit, BRFAA)

Two-D M-mode echocardiography

slide-37
SLIDE 37

Mouse Models of Human Diseases

  • Obesity, insulin

resistance

  • Diabetes
  • Degenerative CNS

disorders

  • Infection, systemic

inflammation

  • Cardiovascular

dysfunction

  • Induced ischemia (TAC)
  • Drug effects (IL15, aDllr4,

Isoproterenol, metformin, rapamycin, insulin, PPAR ligands) and side effects!

Applications of Metabolic phenotyping from our studies so far!.

slide-38
SLIDE 38

In-Silico modeling studies of in vitro and in vivo experiments

General Concepts and Objectives: ! Develop basic model in order to capture the biological knowledge from biological studies. ! Suggest new experiments and feed the results back to the model to improve it. ! Gradually introduce and integrate more components into the model ! Build a computational platform where new hypotheses could be tested in silico

slide-39
SLIDE 39

In-Silico modeling studies of the immune modulatory mechanisms in Inflammatory Bowel Disease

Concept: Inflammatory Bowel Disease results from mis-communication between gut commensal flora and the immune system of the host The ENS is increasingly recognized as a critical component in IBD Objectives:

  • Create the first multi-component computational model of

IBD from mouse and human studies.

  • Elucidate the contribution of cell subsystems in the

restitution of the epithelial barrier.

  • Observe cell behaviors in-silico and generate

new testable hypotheses.

  • Identify specific parts that could likely be manipulated and

suggest new therapeutic approaches for human disease.

slide-40
SLIDE 40

Concept:

  • Duplications and/or mutations of the ASYN gene are linked with familial PD, suggesting

that ASYN levels are crucial for neuronal homeostasis. Modification of ASYN by Dopamine is crucial for homeostatic dysregulations of neurons Objectives: Create a mathematical model aiming to:

  • Simulate the dynamics of ASYN (over)expression
  • ligomerization and the basic biological pathways

involved in the aberrant function of intracellular ASYN.

  • Unravel the unknown critical balance in the levels
  • f intracellular ASYN necessary to cause such

homeostatic dys-regulations

  • Combine and compare biological knowledge

from different biological labs

In silico modeling of Alpha-synuclein oligomerization effects

  • n neuronal homeostasis
slide-41
SLIDE 41

Offset Upstate Onset

  • P. Tsakanikas,

TransMed - RegPot

42 Signal Processing Image Processing Other Electrophysiology Signal Processing & Analysis

Electrophysiology - Time Series Signal Analysis

! Automated Event Detection and Analysis: Release user AND data from making biased estimations!!! The software adapts to the dynamic change of the recording during the recording& ! Additional Properties - User Intervention: $ allow user to modify the limits of the Events $ On-line Quality control of the detected events (discard any mechanical/electrical noise)

Selected Baseline for further processing Estimated Minimum Estimated Maximum

slide-42
SLIDE 42

Introduction Methodology Evaluation Procedure Results & Conclusions Image Analysis & Quantification

Image Analysis & Quantification&

Signal Processing Image Processing Other

Aim: Development of specialized software for Image Analysis and Quantification Developed Software Properties:

  • 1. Fully Automated.
  • 2. High Throughtput Analysis, in order to release users and data from biases.
  • 3. Export the Quantification results in Excel files for further analysis.
  • 4. Applications on Confocal Images, Histological Images, cell cultures and/or videos.

Histological Images Masson's staining Confocal Images Cell Culture – Oil Red O Staining

slide-43
SLIDE 43

Introduction Methodology Evaluation Procedure Results & Conclusions Adipocyte Quantification and Analysis

Adipocyte Quantification and Analysis&

Signal Processing Image Processing Other Fitting of Gaussian Mixture on the Cell Size Distribution Fitting of Gaussian Mixture on the Cell Size Distribution Comparison of cell sizes distributions (HighFat vs. Treated)

Aim: Enumerate and quantify the area of individual adipocytes. Characterize the distributions of cells area in different biological groups. Developed Software: Fully automated, results exported in Excel files, user specific distributions.

Inference of different cell populations using machine learning

slide-44
SLIDE 44

Introduction Methodology Evaluation Procedure Results & Conclusions Heart Rate Estimation

ZebraFish Heart Rate estimation from videos&

Signal Processing Image Processing Other

! Input the video (user) ! Delineate the heart area (approximately) (user) ! The corresponding Heart Rate is displayed along with the estimated signal of the heart-beat (automated) $ Find the fluctuations of the intensity in the area of interest (time-series). $ Fourier analysis in order to find the dominant frequency (Heart Rate). Robust to:

  • 1. small animal movements
  • 2. small light variations during video

acquisition

  • 3. limited (in terms of time) accidental

movement by the user Stand-alone application (2 versions):

  • 1. One video at a time analysis.
  • 2. A series of video exporting results in Excel

The heart must be approximately at the same site for all videos.